83_FR_3018 83 FR 3004 - National Institute of General Medical Sciences; Notice of Closed Meetings

83 FR 3004 - National Institute of General Medical Sciences; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 14 (January 22, 2018)

Page Range3004-3004
FR Document2018-00964

Federal Register, Volume 83 Issue 14 (Monday, January 22, 2018)
[Federal Register Volume 83, Number 14 (Monday, January 22, 2018)]
[Notices]
[Page 3004]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-00964]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of MIRA Applications.
    Date: March 5-6, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda Downtown, 7335 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Brian R. Pike, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Institute of General Medical 
Sciences, National Institutes of Health, 45 Center Drive, Room 
3AN18, Bethesda, MD 20892, 301-594-3907, [email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of IDeA-CTR (U54) 
Applications.
    Date: March 6, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Cambria Suites Rockville, 1 Helen Heneghan Way, 
Rockville, MD 20850.
    Contact Person: Shinako Takada, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
Room 3An.22, Bethesda, MD 20892-6200, 301-402-9448 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives; 93.859, Biomedical Research and 
Research Training, National Institutes of Health, HHS)

    Dated: January 16, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00964 Filed 1-19-18; 8:45 am]
 BILLING CODE 4140-01-P



                                               3004                          Federal Register / Vol. 83, No. 14 / Monday, January 22, 2018 / Notices

                                               attendance limited to space available.                    Dated: January 16, 2018.                             Minority Access to Research Careers; 93.96,
                                               Individuals who plan to attend and                      Melanie J. Pantoja,                                    Special Minority Initiatives; 93.859,
                                                                                                                                                              Biomedical Research and Research Training,
                                               need special assistance, such as sign                   Program Analyst, Office of Federal Advisory
                                                                                                                                                              National Institutes of Health, HHS)
                                               language interpretation or other                        Committee Policy.
                                               reasonable accommodations, should                       [FR Doc. 2018–00958 Filed 1–19–18; 8:45 am]              Dated: January 16, 2018.
                                               notify the Contact Person listed below                  BILLING CODE 4140–01–P                                 Melanie J. Pantoja,
                                               in advance of the meeting. The open                                                                            Program Analyst, Office of Federal Advisory
                                               session will be videocast and can be                                                                           Committee Policy.
                                               accessed from the NIH Videocasting and                  DEPARTMENT OF HEALTH AND                               [FR Doc. 2018–00964 Filed 1–19–18; 8:45 am]
                                               Podcasting website (http://                             HUMAN SERVICES                                         BILLING CODE 4140–01–P

                                               videocast.nih.gov).                                     National Institutes of Health
                                                  The meeting will be closed to the                                                                           DEPARTMENT OF HEALTH AND
                                               public in accordance with the                           National Institute of General Medical                  HUMAN SERVICES
                                               provisions set forth in sections                        Sciences; Notice of Closed Meetings
                                               552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                Pursuant to section 10(d) of the                     National Institutes of Health
                                               as amended. The grant applications and                  Federal Advisory Committee Act, as
                                               the discussions could disclose                                                                                 National Institute of General Medical
                                                                                                       amended, notice is hereby given of the
                                               confidential trade secrets or commercial                                                                       Sciences; Notice of Closed Meeting
                                                                                                       following meetings.
                                               property such as patentable material,                     The meetings will be closed to the                     Pursuant to section 10(d) of the
                                               and personal information concerning                     public in accordance with the                          Federal Advisory Committee Act, as
                                               individuals associated with the grant                   provisions set forth in sections                       amended, notice is hereby given of the
                                               applications, the disclosure of which                   552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,             following meeting.
                                               would constitute a clearly unwarranted                  as amended. The grant applications and                   The meeting will be closed to the
                                               invasion of personal privacy.                           the discussions could disclose                         public in accordance with the
                                                                                                       confidential trade secrets or commercial               provisions set forth in sections
                                                 Name of Committee: National Cancer                    property such as patentable material,                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                               Advisory Board.                                         and personal information concerning                    as amended. The grant applications and
                                                 Date: February 13, 2018.
                                                                                                       individuals associated with the grant                  the discussions could disclose
                                                 Open: 1:00 p.m. to 3:00 p.m.
                                                                                                       applications, the disclosure of which                  confidential trade secrets or commercial
                                                 Agenda: Program reports and
                                                                                                       would constitute a clearly unwarranted                 property such as patentable material,
                                               presentations; business of the Board.
                                                                                                       invasion of personal privacy.                          and personal information concerning
                                                 Closed: 3:00 p.m. to 4:00 p.m.
                                                                                                         Name of Committee: National Institute of             individuals associated with the grant
                                                 Agenda: To review and evaluate grant
                                                                                                       General Medical Sciences Special Emphasis              applications, the disclosure of which
                                               applications.
                                                 Place: National Cancer Institute Shady
                                                                                                       Panel; Review of MIRA Applications.                    would constitute a clearly unwarranted
                                                                                                         Date: March 5–6, 2018.                               invasion of personal privacy.
                                               Grove, 9609 Medical Center Drive, Room                    Time: 8:00 a.m. to 5:00 p.m.
                                               TE406, Rockville, MD 20850 (Virtual                       Agenda: To review and evaluate grant                   Name of Committee: National Institute of
                                               Meeting).                                               applications.                                          General Medical Sciences Special Emphasis
                                                  Contact Person: Paulette S. Gray, Ph.D.,               Place: Residence Inn Bethesda Downtown,              Panel to review COBRE Phase II.
                                               Executive Secretary, Division of Extramural             7335 Wisconsin Avenue, Bethesda, MD                      Date: March 1–2, 2018.
                                                                                                       20814.                                                   Time: 8:00 a.m. to 6:00 p.m.
                                               Activities, National Cancer Institute—Shady
                                                                                                         Contact Person: Brian R. Pike, Ph.D.,                  Agenda: To review and evaluate grant
                                               Grove, National Institutes of Health, 9609                                                                     applications.
                                               Medical Center Drive, Room 7W444,                       Scientific Review Officer, Office of Scientific
                                                                                                       Review, National Institute of General Medical            Place: Hyatt Regency Bethesda, One
                                               Bethesda, MD 20892, 240–276–6340, grayp@                                                                       Bethesda Metro Center, 7400 Wisconsin
                                                                                                       Sciences, National Institutes of Health, 45
                                               mail.nih.gov.                                           Center Drive, Room 3AN18, Bethesda, MD                 Avenue, Bethesda, MD 20814.
                                                  Any interested person may file written               20892, 301–594–3907, pikebr@mail.nih.gov.                Contact Person: Nina Sidorova, Ph.D.,
                                               comments with the committee by forwarding                                                                      Scientific Review Officer, Office of Scientific
                                                                                                         Name of Committee: National Institute of
                                               the statement to the Contact Person listed on                                                                  Review, National Institute of General Medical
                                                                                                       General Medical Sciences Special Emphasis
                                               this notice. The statement should include the                                                                  Sciences, National Institutes of Health, 45
                                                                                                       Panel; Review of IDeA–CTR (U54)
                                               name, address, telephone number and when                                                                       Center Drive, Room 3An.22, Bethesda, MD
                                                                                                       Applications.
                                                                                                                                                              20892–6200, 301–594–3663, sidorova@
                                               applicable, the business or professional                  Date: March 6, 2018.
                                                                                                                                                              nigms.nih.gov.
                                               affiliation of the interested person.                     Time: 8:00 a.m. to 5:00 p.m.
                                                                                                         Agenda: To review and evaluate grant                 (Catalogue of Federal Domestic Assistance
                                                  Information is also available on the
                                                                                                       applications.                                          Program Nos. 93.375, Minority Biomedical
                                               Institute’s/Center’s home page: http://                                                                        Research Support; 93.821, Cell Biology and
                                               deainfo.nci.nih.gov/advisory/ncab/ncab.htm,               Place: Cambria Suites Rockville, 1 Helen
                                                                                                       Heneghan Way, Rockville, MD 20850.                     Biophysics Research; 93.859, Pharmacology,
                                               where an agenda and any additional                                                                             Physiology, and Biological Chemistry
                                                                                                         Contact Person: Shinako Takada, Ph.D.,
                                               information for the meeting will be posted              Scientific Review Officer, Office of Scientific        Research; 93.862, Genetics and
                                               when available.                                         Review, National Institute of General Medical          Developmental Biology Research; 93.88,
                                               (Catalogue of Federal Domestic Assistance               Sciences, National Institutes of Health, 45            Minority Access to Research Careers; 93.96,
                                               Program Nos. 93.392, Cancer Construction;               Center Drive, Room 3An.22, Bethesda, MD                Special Minority Initiatives; 93.859,
                                               93.393, Cancer Cause and Prevention                     20892–6200, 301–402–9448 shinako.takada@               Biomedical Research and Research Training,
ethrower on DSK3G9T082PROD with NOTICES




                                                                                                       nih.gov.                                               National Institutes of Health, HHS)
                                               Research; 93.394, Cancer Detection and
                                               Diagnosis Research; 93.395, Cancer                      (Catalogue of Federal Domestic Assistance                Dated: January 16, 2018.
                                               Treatment Research; 93.396, Cancer Biology              Program Nos. 93.375, Minority Biomedical               Melanie J. Pantoja,
                                               Research; 93.397, Cancer Centers Support;               Research Support; 93.821, Cell Biology and
                                                                                                                                                              Program Analyst, Office of Federal Advisory
                                                                                                       Biophysics Research; 93.859, Pharmacology,
                                               93.398, Cancer Research Manpower; 93.399,                                                                      Committee Policy.
                                                                                                       Physiology, and Biological Chemistry
                                               Cancer Control, National Institutes of Health,          Research; 93.862, Genetics and                         [FR Doc. 2018–00963 Filed 1–19–18; 8:45 am]
                                               HHS)                                                    Developmental Biology Research; 93.88,                 BILLING CODE 4140–01–P




                                          VerDate Sep<11>2014   19:00 Jan 19, 2018   Jkt 244001   PO 00000   Frm 00047   Fmt 4703   Sfmt 9990   E:\FR\FM\22JAN1.SGM   22JAN1



Document Created: 2018-01-23 21:35:48
Document Modified: 2018-01-23 21:35:48
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 5-6, 2018.
FR Citation83 FR 3004 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR